EP0775202A4 - Variantes d'interleukine humaine generees par epissage de remplacement - Google Patents

Variantes d'interleukine humaine generees par epissage de remplacement

Info

Publication number
EP0775202A4
EP0775202A4 EP95915509A EP95915509A EP0775202A4 EP 0775202 A4 EP0775202 A4 EP 0775202A4 EP 95915509 A EP95915509 A EP 95915509A EP 95915509 A EP95915509 A EP 95915509A EP 0775202 A4 EP0775202 A4 EP 0775202A4
Authority
EP
European Patent Office
Prior art keywords
variants
generated
human interleukin
splice
replacement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95915509A
Other languages
German (de)
English (en)
Other versions
EP0775202A1 (fr
Inventor
William Alms
Barbara White
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Maryland Baltimore
University of Maryland College Park
Original Assignee
University of Maryland Baltimore
University of Maryland College Park
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Maryland Baltimore, University of Maryland College Park filed Critical University of Maryland Baltimore
Publication of EP0775202A1 publication Critical patent/EP0775202A1/fr
Publication of EP0775202A4 publication Critical patent/EP0775202A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5406—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP95915509A 1994-03-30 1995-03-30 Variantes d'interleukine humaine generees par epissage de remplacement Withdrawn EP0775202A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21983194A 1994-03-30 1994-03-30
US219831 1994-03-30
US22401094A 1994-04-06 1994-04-06
PCT/US1995/004094 WO1995027052A1 (fr) 1994-03-30 1995-03-30 Variantes d'interleukine humaine generees par epissage de remplacement
US224010 1998-12-31

Publications (2)

Publication Number Publication Date
EP0775202A1 EP0775202A1 (fr) 1997-05-28
EP0775202A4 true EP0775202A4 (fr) 1999-07-14

Family

ID=26914296

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95915509A Withdrawn EP0775202A4 (fr) 1994-03-30 1995-03-30 Variantes d'interleukine humaine generees par epissage de remplacement

Country Status (5)

Country Link
EP (1) EP0775202A4 (fr)
JP (1) JPH09511400A (fr)
AU (1) AU2237395A (fr)
CA (1) CA2186854A1 (fr)
WO (1) WO1995027052A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2241329A3 (fr) 1995-08-24 2011-03-09 Ligand Pharmaceuticals Incorporated Anticorps anti-interleukin-9 ou anticorps du récepteur anti-interleukin-9 pour le traitment de la hyper-réponse bronchique
US6881571B1 (en) 1998-03-11 2005-04-19 Exonhit Therapeutics S.A. Qualitative differential screening
FR2775984B1 (fr) * 1998-03-11 2006-09-15 Bioscreen Therapeutics Sa Criblage differentiel qualitatif
US6335426B1 (en) 1996-06-14 2002-01-01 Bayer Corporation T-cell selective interleukin-4 agonists
US5986059A (en) * 1996-06-14 1999-11-16 Bayer Corporation T-cell selective interleukin-4 agonists
US6028176A (en) * 1996-07-19 2000-02-22 Bayer Corporation High-affinity interleukin-4 muteins

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CIARDELLI T.L. ET AL.: "Structural sudies of interleukin 2", PEPTIDES: STRUCTURE & FUNCTION: PROCEEDINGS OF THE AMERICAN PEPTIDE SYMPOSIUM. EDS: DEBER C.M., HRUBY V.J., KOPPLE K.D.; PUB: PIERCE CHEMICAL CO, ROCKFORD (IL) USA, vol. 9, 1985, pages 75 - 78, XP002100685 *
See also references of WO9527052A1 *
SORG R. ET AL.: "Expression of alternatively spliced mRNAs for IL-2, IL-4, IL-5, G-CSF, and GM-CSF", SYMPOSIUM ON SECRETED CYTOKINES II; ABSTRACTS OF THE II INTERNATIONAL SYMPOSIUM ON CYTOKINES IN HEMOPOIESIS, ONCOLOGY AND AIDS, HANNOVER 12-22 JUNE 1991, XP002100687 *
SORG R. ET AL.: "Rapid and sensitive mRNA phenotyping for interleukins (IL-1 to IL-6) and Colony-stimulating Factors (G-CSF and GM-CSF) by reverse transcription and subsequent polymerase chain reaction", EXPERIMENTAL HEMATOLOGY, vol. 19, no. 9, 1991, pages 882 - 887, XP002100686 *

Also Published As

Publication number Publication date
AU2237395A (en) 1995-10-23
EP0775202A1 (fr) 1997-05-28
WO1995027052A1 (fr) 1995-10-12
CA2186854A1 (fr) 1995-10-12
JPH09511400A (ja) 1997-11-18

Similar Documents

Publication Publication Date Title
EP0691821A4 (fr) Systeme d'electrode medicale amovible
EP0736303A3 (fr) Solution d'interféron
EP0902665A4 (fr) Therapie de remplacement des strogenes par des phytoestrogenes alimentaires
FI972431A0 (fi) Sytotoksisten T-lymfosyyttivasteiden induktio
DE59510409D1 (de) Flexible künstliche nervenplatte
EP0752844A4 (fr) Cathepsine humaine derivee d'osteoclastes
BR9503111A (pt) Lanterna de Mao
EP0746377A4 (fr) Compresses d'application d'agents therapeutiques agencees en tandem
EP0765166A4 (fr) Conjugues radiomarques d'annexine-galactose
BR9507166A (pt) Conjunto de dentes para tratamento de uma superfície
IT1276823B1 (it) Procedimento per la purificazione dell'acetone
EP0721012A3 (fr) Récepteur de motilité médiée par l'acide hyaluronique
BR9607427A (pt) Inibiçao de angiogêne usando interleucina 12
IT1271567B (it) Procedimento per l'ulteriore trattamento di salcicce
ITRM950861A0 (it) Procedimento per l'assemblaggio di semilavorati per calze-mutanda
EP0764204A4 (fr) OXALYL-CoA DECARBOXYLASE HUMAINE
ITMI940892A0 (it) Procedimento per il conferimento di prorpeita' antibatteriche agli spazzolini da denti
EP0815220A4 (fr) Transporteur d'amine humaine
EP0787013A4 (fr) Hypoxanthine-(guanine) phosphoribosyltransferase-2 humaine
ATA112393A (de) Abnehmbarer zahnersatz
EP0804226A4 (fr) Choline-acetylase humaine
KR960036325U (ko) 삽입식 교체형 지압기
EP0815199A4 (fr) Desoxycytidine kinase 2 humaine
KR960033538U (ko) 치과용 시린지의 착탈구조
EP0842187A4 (fr) Cystatine e humaine

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19961028

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: LT;SI

A4 Supplementary search report drawn up and despatched

Effective date: 19990601

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19990818